// App-Quantinova.ai

TCT-68 : Chronic Total Occlusion Percutaneous Coronary Intervention for Patients With Previous CABG: Insights From a Pooled Analysis of 4 Multicenter Registries

Researchers

Presenter

  • Evangelia Vemmou

Principal Investigators

  • Joseph Dens

  • Nidal Abi Rafeh

  • Pierfrancesco Agostoni

  • Khaldoon Alaswad

  • Alexandre Avran

  • Karlyse Belli

  • Carlos Campos

  • Mauro Carlino

  • James Choi

  • Felix Damas de los Santos

  • Ahmed ElGuindy

  • Farouc Amin Jaffer

  • Dimitri Karmpaliotis

  • Jaikirshan Khatri

  • Dmitrii Khelimskii

  • Paul Knaapen

  • Oleg Krestyaninov

  • Alessio La Manna

  • Pablo Lamelas

  • Soledad Ojeda

  • Lucio Padilla

  • Manuel Pan

  • Pedro Piccaro De Oliveira

  • Stephane Rinfret

  • Ricardo Santiago

  • James Spratt

  • Simon Walsh

  • Spyridon Kostantinis

  • Bahadir Simsek

  • Judit Karacsonyi

  • Ilias Nikolakopoulos

  • Bavana Rangan

  • Emmanouil Brilakis

  • Lorenzo Azzalini

Medical Centers

  • Cleveland Clinic Cleveland Ohio USA

  • ICBA, San Isidro - Buenos Aires, Argentina

  • Pasteur Clinic, Essey Les Nancy, France

  • Reina Sofia Hospital, Córdoba, Spain

  • Royal Victoria Hospital, Belfast, United Kingdom

  • Instituto de Cardiologia do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

  • IRCCS San Raffaele Scientific Institute, Milan, Italy

  • VU University Medical Center, Amsterdam, Netherlands

  • Instituto Nacional de Cardiología, Mexico City, Federal District, Mexico

  • Instituto Cardiovascular de Buenos Aires, Buenos Aires, Argentina

  • Policlinico University Hospital, Catania, Italy

  • St. George Hospital University Medical Center, Beirut, Lebanon

  • Baylor University Medical Center, Dallas, Texas, USA

  • Ziekenhuis Oost Limburg, Genk, Belgium

  • Henry Ford Hospital Detroit Michigan USA

  • VCU Health Pauley Heart Center, Richmond, Virginia, USA

  • Magdi Yacoub Heart Foundation, Cairo, Egypt

  • Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil

  • Emory University Atlanta Georgia USA

  • ZNA Middelheim, Antwerp, Belgium

  • Meshalkin National Research Center, Novosibirsk, Russian Federation

  • PCI Cardiology Group, Dorado, Puerto Rico, USA

  • Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA

  • Minneapolis Heart Institute Foundation Minneapolis, Minnesota and Yale School of Medicine, New Haven, Connecticut, USA

  • Hospital Moinhos de Vento, Porto Alegre, Rio Grande do Sul, Brazil

  • St. George's Hospital University Trust, London, United Kingdom

  • Massachusetts General Hospital/Harvard Medical School, Boston, Massachusetts

  • Minneapolis Heart Institute, Minneapolis, Minnesota, USA

  • Meshalkin Siberian Federal Biomedical Research Center, Novosibirsk, Russian Federation

  • NewYork–Presbyterian/Columbia University Irving Medical Center, New York, New York, USA

Locations

  • United States

  • Brazil

  • Argentina

  • Egypt

  • France

  • Spain

  • United Kingdom

  • Belgium

  • Russia

  • Italy

  • Netherlands

  • Mexico

  • Lebanon

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Central Nervous System (CNS)

Disease

  • Chronic total occlusion

  • Myocardial infarction

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved